Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Applied Genetic Tech's Shares Double on 6-Month X-Linked RP Study Results

Shares of Applied Genetic Technologies skyrocketed to a new 52-week high price after the company reported positive six-month data from its ongoing Phase 1/2 clinical study for treatment in X-Linked Retinitis Pigmentosa. The firm stated that the trial data suggests durable and ...

How to trade gold with ETFs and options

With few exceptions , most leading financial gurus agree that every portfolio should include some physical gold. But while the yellow metal itself is great as a long-term hedge against turmoil and inflation, it's a lousy trading vehicle. Here's why. For shorter-term t...

Aurora Cannabis, Lufthansa, Saturn Oil & Gas, TUI - the twofold candidates

In the context of the Corona Pandemic, share prices came under pressure from numerous sectors and companies. The continued existence of renowned companies was at risk shortly after the announcement of measures against the spread of Covid-19. In order to prevent worse, the stat...

Coverage Initiated on Biopharma With 'Low Risk/High Margin Assets'

The case is made in a ROTH Capital Partners report for investing in this U.S.-based pharma having multiple shots on goal. In a June 30 research note, analyst Scott Henry reported that ROTH Capital Partners initiated coverage on Fortress Biotech Inc. (FBIO:NASDAQ) ...

Gold as a Strategic Asset - in 2019 and Beyond

Recently, the World Gold Council published a 2019 edition of a report on gold as a strategic asset . The industry organization released later the UK edition as well. Plenty of food for thought. How can the learnings from these publications strengthen our investment decisi...

From Cystic Fibrosis to COVID-19: A Medical Solution Like No Other

(Image via Dymedso Inc.) Airway clearance therapy has been a cornerstone of treatments aimed at minimizing the devastating effects of airway obstruction, infection, and inflammation caused by a buildup of mucus in lung conditions … but finding a non-invasive solutio...

Varta, Rock Tech Lithium, Millennial Lithium - all signs point to growth

ON THE AUTHOR: Carsten Mainitz The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research. Most r...

Canadian Cobalt Pure Play to Combine with Australian Metals Explorer

The details and implications of the deal are discussed in a Canaccord Genuity report. In an April 9 research note, Canaccord Genuity analyst Eric Zaunscherb reported that eCobalt Solutions Inc. (ECS:TSX; ECSIF:OTCQX; ECO:FSE) agreed to merge with Jervois Mining. "The ...

Ballard Power, dynaCERT, NEL ASA - which hydrogen technology has potential?

The topic of hydrogen in mobility is currently occupying the economy, politics and investors. The stock market is looking for companies that develop solutions with the energy carrier of the future, because hydrogen can be used as an energy storage medium in electric mobility a...

U.S. Biotech Makes 'The Acquisition We Were Waiting For'

By tucking in this retinal gene therapy firm, the Massachusetts-based company gains assets and synergy. In a March 4 BTIG research note, analyst Thomas Shrader reported that Biogen Inc. (BIIB:NASDAQ) entered into an agreement to acquire Nightstar Therapeutics Pl...
1 2 3 4 5 6 7 8 9 10 ...